文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Muscle Strength and Cardiovascular Health in MASLD: A Prospective Study.

作者信息

Kumbaroğlu Birgül Fatma, Balaban Yasemin Hatice, Düger Tülin

机构信息

Faculty of Physical Therapy and Rehabilitation, Hacettepe University, Ankara 06100, Turkey.

Faculty of Medicine, Department of Gastroenterology, Hacettepe University, Ankara 06100, Turkey.

出版信息

Medicina (Kaunas). 2025 Feb 1;61(2):247. doi: 10.3390/medicina61020247.


DOI:10.3390/medicina61020247
PMID:40005364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11857117/
Abstract

: The pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD) remains incompletely understood. However, recent studies highlight the interactions between muscle, liver, and adipose tissue. This study aimed to explore the relationships between clinical indicators of MASLD and sarcopenia, cardiorespiratory fitness, fatigue, and mood. : The study involved 60 participants, including 28 healthy controls and 32 with MASLD, categorized into two disease subgroups: 15 with MASL and 17 with metabolic dysfunction-associated steatohepatitis (MASH). Participants completed an incremental speed shuttle walk test to evaluate cardiorespiratory fitness, a hand-held dynamometer assessment for appendicular muscle strength, and the timed up and go test for physical performance. Physical activity level, fatigue, quality of life, and emotional state were assessed using questionnaires. The test results were compared between groups and with disease characteristics. : MASL and MASH groups showed reduced cardiorespiratory fitness ( < 0.001). The knee extensors were significantly weaker in both MASL and MASH groups ( < 0.001 and = 0.001, respectively). The MASH group reported higher levels of depression and negative health perception ( = 0.006 and = 0.03, respectively). Muscle strength in patients with MASLD showed a significant negative association with depression (OR = -0.384, 95% CI: -3.10 to -0.74, = 0.003), intrahepatic triglyceride content (OR = -0.287, 95% CI: -1.31 to -0.11, = 0.023), and LDL (OR = -0.286, 95% CI: -0.02 to -0.33, = 0.03). In contrast, a positive association was observed between VO and muscle strength (OR = 0.531, 95% CI 1.27 to 3.47, < 0.001). : This study suggests that muscle strength is linked to key metabolic parameters, such as hepatic fat, LDL levels, and aerobic capacity, that may contribute to the development and progression of MASLD. Interventions aimed at preserving or enhancing muscle strength in MASLD patients may be essential for preventing liver damage and improving metabolic health.

摘要

相似文献

[1]
Muscle Strength and Cardiovascular Health in MASLD: A Prospective Study.

Medicina (Kaunas). 2025-2-1

[2]
Association of muscle mass, grip strength and fat-to-muscle ratio and metabolic dysfunction-associated steatotic liver disease in a middle-to-elderly aged population.

Ann Med. 2024-12

[3]
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.

Cochrane Database Syst Rev. 2016-3-31

[4]
Weight Loss After Sleeve Gastrectomy According to Metabolic Dysfunction-Associated Steatotic Liver Disease Stage in Patients with Obesity: A Liver Biopsy-Based Prospective Study.

Nutrients. 2024-11-12

[5]
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases.

Front Cell Dev Biol. 2024-7-16

[6]
Deep phenotyping of patients with MASLD upon high-intensity interval training.

JHEP Rep. 2024-12-16

[7]
Presence of Mood and/or Anxiety Disorders Does Not Affect Success of Weight Management Therapies in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Dig Dis Sci. 2025-1

[8]
Impact of steatotic liver disease subtypes, sarcopenia, and fibrosis on all-cause and cause-specific mortality: a 15.7-year cohort study.

BMC Gastroenterol. 2025-2-11

[9]
Risk-stratified hepatocellular carcinoma screening according to the degree of obesity and progression to cirrhosis for diabetic patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Japan: a cost-effectiveness study.

BMJ Open. 2024-11-5

[10]
The role of PCSK9 in metabolic dysfunction-associated steatotic liver disease and its impact on bariatric surgery outcomes.

Surg Obes Relat Dis. 2024-7

本文引用的文献

[1]
Effect of short-term exercise-based prehabilitation program for patients undergoing liver cancer surgery: A randomized controlled trial.

Surgery. 2025-4

[2]
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.

Circulation. 2025-1-7

[3]
From MASLD to PAD: Looking for Cardiovascular Disease Starting from Metabolic Status.

Medicina (Kaunas). 2024-10-31

[4]
Updated mechanisms of MASLD pathogenesis.

Lipids Health Dis. 2024-4-22

[5]
Increased visceral fat area to skeletal muscle mass ratio is positively associated with the risk of metabolic dysfunction-associated steatotic liver disease in a Chinese population.

Lipids Health Dis. 2024-4-14

[6]
Current status and future trends of the global burden of MASLD.

Trends Endocrinol Metab. 2024-8

[7]
Prehabilitation in patients awaiting liver transplantation.

Transplant Rev (Orlando). 2024-4

[8]
Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease.

Aliment Pharmacol Ther. 2024-1

[9]
NAFLD Associates with Sarcopenia Defined by Muscle Mass and Slow Walking Speed: A Cross-Sectional Analysis from the Framingham Heart Study.

J Clin Med. 2023-12-6

[10]
Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide study.

World J Gastroenterol. 2023-12-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索